Intervention study on autoimmune bullous diseases with imatinib - IABD
Autoimmune bullous disease including pemphigus group and pemphigoid group;D012872
Imatinib 800 mg a day p.o. for seven days will be started within 14 days of starting steroid therapy (and when the bed is secured). Imatinib 800 mg a day p.o. for seven days will be started afterregistered in the trial (and when the bed is secured) in patients with mild symptoms and will not take systemic steroid therapy. Imatinib800 mg a day p.o. for seven days will be started within 14 days of starting steroid therapy ...